ProKidney Statistics
NASDAQ: PROKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.04-0.02 (-1.89%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ProKidney by the numbers
ProKidney has a market capitalization of $415.2 million based on 209.63M shares outstanding. With trailing EPS of $-0.61, ProKidney is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.1% below its 50-day average and 40.3% below its 200-day average.
Average daily trading volume is 1.44M shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PROK valuation vs. peer median
| Metric | PROK | Peer median | Difference |
|---|---|---|---|
| Market cap | $415.21M | $418.81M | -1% |
| Avg. volume | 1.44M | 742.62K | +93% |
Peer median across 8 companies: TECX, TVGN, IRLA, CADL, FENC, RGNX, SANA, ALEC.
Valuation
- Market cap
- $415.21M
- Price / sales (latest FY)
- 464.96
- EPS (TTM)
- $-0.61
- Shares outstanding
- 209.63M
Price and trading
- Previous close
- 1.06
- Open
- 1.03
- Day range
- 1.02 – 1.08
- 52-week range
- 0.87 – 2.65
- 52-week change
- -52.51%
- Beta
- —
- Volume
- 1.90M
- Average volume
- 1.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 415.21M
- Forward Pe
- -1.66
- Eps
- -0.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.65
- Week52 Low
- 0.87
- Avg Volume
- 1.44M
- Shares Outstanding
- 209.63M
- Ma50
- 1.45
- Ma200
- 1.74
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -60.75%
- Pct From52w Low
- 19.54%